MY8700934A - Pharmaceutical compositions comprising 7,8-dihydroxy-i(hydroxyphenyl)-2,3,4,5-tetrahydro-ih-3-benzazepine derivatives and a beta-adrenergic blocking compound - Google Patents

Pharmaceutical compositions comprising 7,8-dihydroxy-i(hydroxyphenyl)-2,3,4,5-tetrahydro-ih-3-benzazepine derivatives and a beta-adrenergic blocking compound

Info

Publication number
MY8700934A
MY8700934A MY934/87A MY8700934A MY8700934A MY 8700934 A MY8700934 A MY 8700934A MY 934/87 A MY934/87 A MY 934/87A MY 8700934 A MY8700934 A MY 8700934A MY 8700934 A MY8700934 A MY 8700934A
Authority
MY
Malaysia
Prior art keywords
tetrahydro
dihydroxy
hydroxyphenyl
beta
adrenergic blocking
Prior art date
Application number
MY934/87A
Other languages
English (en)
Inventor
Ackerman Dennis Marvin
Berkowitz Barry Alan
Wiebelhaus Virgil Daniel
Original Assignee
Smithkline Beckman Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beckman Corp filed Critical Smithkline Beckman Corp
Publication of MY8700934A publication Critical patent/MY8700934A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
MY934/87A 1981-12-08 1987-12-30 Pharmaceutical compositions comprising 7,8-dihydroxy-i(hydroxyphenyl)-2,3,4,5-tetrahydro-ih-3-benzazepine derivatives and a beta-adrenergic blocking compound MY8700934A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP81110252A EP0081006B1 (en) 1981-12-08 1981-12-08 Pharmaceutical compositions comprising 7,8-dihydroxy-1(hydroxyphenyl)-2,3,4,5-tetrahydro-1h-3-benzazepine derivatives and a beta-adrenergic blocking compound

Publications (1)

Publication Number Publication Date
MY8700934A true MY8700934A (en) 1987-12-31

Family

ID=8188060

Family Applications (1)

Application Number Title Priority Date Filing Date
MY934/87A MY8700934A (en) 1981-12-08 1987-12-30 Pharmaceutical compositions comprising 7,8-dihydroxy-i(hydroxyphenyl)-2,3,4,5-tetrahydro-ih-3-benzazepine derivatives and a beta-adrenergic blocking compound

Country Status (18)

Country Link
US (1) US4469690A (enExample)
EP (1) EP0081006B1 (enExample)
JP (1) JPS58105921A (enExample)
AT (1) ATE15762T1 (enExample)
AU (1) AU550892B2 (enExample)
CA (1) CA1183777A (enExample)
DE (1) DE3172458D1 (enExample)
GR (1) GR77842B (enExample)
HK (1) HK11489A (enExample)
HU (1) HU187804B (enExample)
IL (1) IL67310A (enExample)
MY (1) MY8700934A (enExample)
NZ (1) NZ202510A (enExample)
PH (1) PH22073A (enExample)
PT (1) PT75915B (enExample)
SG (1) SG61188G (enExample)
ZA (1) ZA829004B (enExample)
ZW (1) ZW25482A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0365134A1 (en) * 1988-09-16 1990-04-25 Smithkline Beecham Corporation Synergistic compositions of renal dopaminergic agent and angiotensin converting enzyme inhibitors
CA2056405A1 (en) * 1990-04-06 1991-10-07 Mitsumasa Shino Solid oral preparation containing catechol compound
ATE473759T1 (de) 1998-05-22 2010-07-15 Univ Leland Stanford Junior Bifunktionelle moleküle sowie darauf basierende therapien.
AU2002322720B2 (en) 2001-07-25 2008-11-13 Raptor Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
US7022342B2 (en) 2002-03-28 2006-04-04 Andrx Corporation, Inc. Controlled release oral dosage form of beta-adrenergic blocking agents
CN102379684B (zh) 2005-04-28 2014-11-19 普罗透斯数字保健公司 药物信息系统
KR20090071598A (ko) 2006-09-18 2009-07-01 랩터 파마슈티컬 인코포레이티드 수용체 결합 단백질(ｒａｐ)-접합체 투여에 의한 간 질환의 치료
EP2398500B1 (en) 2009-02-20 2019-03-13 2-BBB Medicines B.V. Glutathione-based drug delivery system
ES2942923T3 (es) 2009-05-06 2023-06-07 Laboratory Skin Care Inc Composiciones de administración dérmica que comprenden complejos de agente activo-partículas de fosfato de calcio y métodos de uso de las mismas
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4011319A (en) * 1975-07-02 1977-03-08 Smithkline Corporation Pharmaceutical compositions and methods involving benzazepine derivatives
DE2638716A1 (de) * 1976-08-27 1978-03-02 Ici Gmbh Antihypertensiva
US4160765A (en) * 1976-11-17 1979-07-10 Smithkline Corporation Method for 6-bromination of 1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine compounds
US4171359A (en) * 1978-04-12 1979-10-16 Smithkline Corporation Benz-tetrasubstituted 1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines
US4265889A (en) * 1978-05-05 1981-05-05 Smithkline Corporation 6-Lower alkyl-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines
US4192297A (en) * 1978-05-25 1980-03-11 Leopold Labrecque Therapeutic feet bathing device
DE2850078A1 (de) * 1978-11-18 1980-05-29 Basf Ag Aminopropanolderivate des 6-hydroxy-2,3,4,5-tetrahydro-1h-1- benzazepin-2-ons
EP0022330B1 (en) * 1979-07-10 1983-12-21 Smithkline Beckman Corporation Synergistic antihypertensive compositions

Also Published As

Publication number Publication date
ATE15762T1 (de) 1985-10-15
HU187804B (en) 1986-02-28
EP0081006A1 (en) 1983-06-15
US4469690A (en) 1984-09-04
DE3172458D1 (en) 1985-10-31
AU9084482A (en) 1983-06-16
IL67310A (en) 1988-09-30
EP0081006B1 (en) 1985-09-25
ZW25482A1 (en) 1983-02-23
PH22073A (en) 1988-05-20
PT75915B (en) 1985-11-15
JPS58105921A (ja) 1983-06-24
SG61188G (en) 1989-07-07
PT75915A (en) 1982-12-01
CA1183777A (en) 1985-03-12
GR77842B (enExample) 1984-09-25
NZ202510A (en) 1985-09-13
ZA829004B (en) 1983-09-28
HK11489A (en) 1989-02-17
AU550892B2 (en) 1986-04-10

Similar Documents

Publication Publication Date Title
IE862554L (en) Pharmaceutical compositions
ES527776A0 (es) Procedimiento de preparacion de derivados de 1,4-dihidropiridinas.
BG43866A3 (en) Method for preparing of derivatives of 2, 2'- imino- bis- ethanol
ES511955A0 (es) "procedimiento para la preparacion de derivados de cefem".
DE3366494D1 (de) New 6-substituted-s-triazolo(3,4-a)phthalazine derivatives
IT8467225A1 (it) Composti di solfonio, procedimento di preparazione di detti composti e composizioni farmacologiche contenenti i composti stessi.
CA1251462C (enExample)
DE3172458D1 (en) Pharmaceutical compositions comprising 7,8-dihydroxy-1(hydroxyphenyl)-2,3,4,5-tetrahydro-1h-3-benzazepine derivatives and a beta-adrenergic blocking compound
ES515728A0 (es) "procedimiento para la preparacion de nuevos derivados de azepina".
OA07525A (fr) Dérivés d'acides-animés, leur préparation et utilisation ainsi que les compositions contenant ces dérivés.
MX9202935A (es) Derivados de 2,3-dihidro-1h-indeno y composicion farmaceutica que los contiene.
ES513672A0 (es) "procedimiento para la preparacion de derivados de penem".
IL72188A (en) 7-piperidino-1,2,3,5-tetrahydroimidazo(2,1-b)-quinazolin-2-one and salts thereof,their preparation and pharmaceutical compositions containing them
ES510730A0 (es) "procedimiento para la preparacion de (2,2')-disulfuros de ditiazolilo".
KR910009270A (ko) 15-케토-프로스타글란딘 화합물을 이용한 심기능장애의 치료방법
ES513974A0 (es) Procedimiento de preparacion de derivados del 3,4-difenil-5-metil pirazol.
ES513619A0 (es) "procedimiento para la preparacion de derivados de 1-azolil-2-hidroxi-alcano".
GB1511196A (en) Creatinine pyrolidonecarboxylate
ES511107A0 (es) "procedimiento para la preparacion de 3-hidroxi-1,2,4-triazoles".
ES514844A0 (es) "procedimiento para la preparacion de derivados de 5(6)-fenil-sulfoniloxi-bencimidazol".
ES518725A0 (es) Procedimiento de preparacion de nuevos derivados del azabiciclo (3.2.0) heptano.
ES516069A0 (es) "procedimiento para la preparacion de derivados de 1,2,3-tiadiazol-5-il-urea".
GR852224B (enExample)
ES509948A0 (es) "procedimiento para la preparacion de derivados de 2-oxa-biciclo (3.3.0) octano".
ES515801A0 (es) "procedimiento para la preparacion de derivados de 1,2,3-tiadiazol-5-il-urea".